SCHEMBL16834201

SCHEMBL16834201

N=S(N)(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15866540 0.78
Sulfamide SCHEMBL3066811 0.78
SCHEMBL31031176 0.78
Sulfamide SCHEMBL19639013 0.75
SCHEMBL41623 0.75
Sulfamide SCHEMBL11308044 0.75
Hydrochloric Acid SCHEMBL19411377 0.75
Sulfamide SCHEMBL5880 0.72
SCHEMBL20680965 0.69
SCHEMBL21841869 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188284-A1 CAGING-GROUP-FREE PHOTOACTIVATABLE FLUORESCENT DYES AND THEIR USE MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E. V. (DE) 2025-06-12 US disclosed
EP-3180330-B1 2,2,2-TRIFLUOROETHYL-THIADIAZINES HOFFMANN LA ROCHE (CH) 2021-03-03 EP disclosed
US-10829500-B2 Pyridyl-triazabicycles HOFFMANN-LA ROCHE INC. (US) 2020-11-10 US disclosed
US-20190352312-A1 PYRIDYL-TRIAZABICYCLES HOFFMANN-LA ROCHE INC. 2019-11-21 US disclosed
US-10414780-B2 Pyridyl-triazabicycles HOFFMANN-LA ROCHE INC. (US) 2019-09-17 US disclosed
EP-3083644-B1 5-ARYL-1-IMINO-1-OXO-[1,2,4]THIADIAZINES HOFFMANN LA ROCHE (CH) 2019-03-13 EP disclosed
EP-3172206-B1 PYRIDYL-TRIAZABICYCLES HOFFMANN LA ROCHE (CH) 2019-01-30 EP disclosed
US-20180312528-A1 PYRIDYL-TRIAZABICYCLES HOFFMANN-LA ROCHE INC. 2018-11-01 US disclosed
US-20180194779-A1 PYRIDYL-TRIAZABICYCLES F. HOFFMANN-LA ROCHE AG (CH) 2018-07-12 US disclosed
EP-3339297-A1 SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI BASF SE (DE) 2018-06-27 EP disclosed
US-9896438-B2 2,2,2-trifluoroethyl-thiadiazines HOFFMANN-LA ROCHE INC. (US) 2018-02-20 US disclosed
US-20170226091-A1 2,2,2-TRIFLUOROETHYL-THIADIAZINES HOFFMANN-LA ROCHE INC. 2017-08-10 US disclosed
EP-3180330-A1 2,2,2-TRIFLUOROETHYL-THIADIAZINES F. Hoffmann-La Roche AG (CH) 2017-06-21 EP disclosed
EP-3172206-A1 PYRIDYL-TRIAZABICYCLES F. Hoffmann-La Roche AG (CH) 2017-05-31 EP disclosed
US-9605006-B2 5-aryl-1-imino-1-oxo-[1,2,4]thiadiazines HOFFMANN-LA ROCHE INC. (US) 2017-03-28 US disclosed
US-20160318952-A1 5-ARYL-1-IMINO-1-OXO-[1,2,4]THIADIAZINES HOFFMANN-LA ROCHE INC. (US) 2016-11-03 US disclosed
EP-3083644-A1 5-ARYL-1-IMINO-1-OXO-[1,2,4]THIADIAZINES F. Hoffmann-La Roche AG (CH) 2016-10-26 EP disclosed
WO-2016023927-A1 2,2,2-TRIFLUOROETHYL-THIADIAZINES F. HOFFMANN-LA ROCHE AG (CH) 2016-02-18 WO disclosed
WO-2016012422-A1 PYRIDYL-TRIAZABICYCLES F. HOFFMANN-LA ROCHE AG (CH) 2016-01-28 WO disclosed
WO-2015091595-A1 5-ARYL-1-IMINO-1-OXO-[1,2,4]THIADIAZINES F. HOFFMANN-LA ROCHE AG (CH) 2015-06-25 WO disclosed